Glucose can react with the lysine residues of low-density lipoproteins (LDLs) and convert the lipoprotein to a form with a receptor-mediated uptake by cultured cells that is impaired. However, in contrast to other modified lipoproteins taken up by both murine and human macrophages via the scavenger-receptor pathway that may induce the formation of foam cells, glycosylated LDL is not recognized by murine macrophages, and thus far, it has not been shown to lead to marked intracellular accumulation of cholesterol in human macrophages. This study illustrates that glycosylated LDL incubated with human monocyte-derived macrophages, at a concentration of 100 micrograms LDL/ml medium, stimulates significantly more cholesteryl ester (CE) synthesis than does control LDL (10.65 ± 1.5 vs. 4.8 ± 0.13 nmol.· mg−1 cell protein · 20 h−1; P < .05). At LDL concentrations similar to those of plasma, the rate of CE synthesis in macrophages incubated with glycosylated LDL is more markedly enhanced than that observed in cells incubated with control LDL (3-fold increase). The marked stimulation of CE synthesis in human macrophages exposed to glycosylated LDL is paralleled by a significant increase in CE accumulation in these cells (P < .001). The increase in CE synthesis and accumulation seem to be mediated by an increase in the degradation of glycosylated LDL by human macrophages. Glycosylated LDL enters the macrophages and is degraded by the classic LDL-receptor pathway in slightly smaller amounts than control LDL, but its degradation by pathways other than the classic LDL receptor or scavenger receptor is markedly enhanced. These studies have shown a possible mechanism by which glycosylation of LDL may lead to the formation of foam cells and contribute to the acceleration of atherosclerosis in diabetes mellitus.
Skip Nav Destination
Article navigation
Original Articles|
May 01 1988
Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages
Maria F Lopes-Virella;
Maria F Lopes-Virella
Veterans Administration Medical Center and Endocrinology-Metabolism-Nutrition Division, Department of Medicine, Medical University of South Carolina
Charleston, South Carolina
Biological Response Modifiers Program, National Institutes of Health
Frederick, Maryland
Division of Metabolic Disease, Department of Medicine, University of California at San Diego
La Jolla, California
Search for other works by this author on:
Richard L Klein;
Richard L Klein
Veterans Administration Medical Center and Endocrinology-Metabolism-Nutrition Division, Department of Medicine, Medical University of South Carolina
Charleston, South Carolina
Biological Response Modifiers Program, National Institutes of Health
Frederick, Maryland
Division of Metabolic Disease, Department of Medicine, University of California at San Diego
La Jolla, California
Search for other works by this author on:
Timothy J Lyons;
Timothy J Lyons
Veterans Administration Medical Center and Endocrinology-Metabolism-Nutrition Division, Department of Medicine, Medical University of South Carolina
Charleston, South Carolina
Biological Response Modifiers Program, National Institutes of Health
Frederick, Maryland
Division of Metabolic Disease, Department of Medicine, University of California at San Diego
La Jolla, California
Search for other works by this author on:
Henry C Stevenson;
Henry C Stevenson
Veterans Administration Medical Center and Endocrinology-Metabolism-Nutrition Division, Department of Medicine, Medical University of South Carolina
Charleston, South Carolina
Biological Response Modifiers Program, National Institutes of Health
Frederick, Maryland
Division of Metabolic Disease, Department of Medicine, University of California at San Diego
La Jolla, California
Search for other works by this author on:
Joseph L Witztum
Joseph L Witztum
Veterans Administration Medical Center and Endocrinology-Metabolism-Nutrition Division, Department of Medicine, Medical University of South Carolina
Charleston, South Carolina
Biological Response Modifiers Program, National Institutes of Health
Frederick, Maryland
Division of Metabolic Disease, Department of Medicine, University of California at San Diego
La Jolla, California
Search for other works by this author on:
Address correspondence and reprint requests to Maria F. Lopes-Virella, MD, VA Medical Center (151), 109 Bee Street, Charleston, SC 29403.
Diabetes 1988;37(5):550–557
Article history
Received:
September 02 1986
Revision Received:
October 15 1987
Accepted:
October 15 1987
PubMed:
3129328
Citation
Maria F Lopes-Virella, Richard L Klein, Timothy J Lyons, Henry C Stevenson, Joseph L Witztum; Glycosylation of Low-Density Lipoprotein Enhances Cholesteryl Ester Synthesis in Human Monocyte-Derived Macrophages. Diabetes 1 May 1988; 37 (5): 550–557. https://doi.org/10.2337/diab.37.5.550
Download citation file:
61
Views